Dignitana AB (ST:DIGN) — Market Cap & Net Worth
Market Cap & Net Worth: Dignitana AB (DIGN)
Dignitana AB (ST:DIGN) has a market capitalization of $18.55 Million (Skr172.36 Million) as of September 17, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #25461 globally and #511 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dignitana AB's stock price Skr2.14 by its total outstanding shares 80541904 (80.54 Million). Also see Dignitana AB assets under control for a full breakdown of the balance sheet.
Dignitana AB Market Cap History: 2015 to 2025
Dignitana AB's market capitalization history from 2015 to 2025. Data shows change from $184.62 Million to $18.55 Million (-17.98% CAGR). Also see Dignitana AB cash conversion from operations for how efficiently the company converts equity into cash flow.
Index Memberships
Dignitana AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.22 Billion | 0.12% | #112 of 281 |
Weight: Dignitana AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Dignitana AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dignitana AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check DIGN share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.09x
Dignitana AB's market cap is 0.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $184.62 Million | $4.75 Million | -$16.57 Million | 38.88x | N/A |
| 2016 | $167.28 Million | $8.90 Million | -$32.27 Million | 18.79x | N/A |
| 2017 | $26.70 Million | $22.94 Million | -$42.60 Million | 1.16x | N/A |
| 2018 | $47.67 Million | $33.74 Million | -$26.02 Million | 1.41x | N/A |
| 2019 | $74.37 Million | $40.70 Million | -$38.03 Million | 1.83x | N/A |
| 2020 | $71.42 Million | $46.63 Million | -$54.93 Million | 1.53x | N/A |
| 2021 | $75.93 Million | $57.07 Million | -$43.09 Million | 1.33x | N/A |
| 2022 | $44.46 Million | $73.00 Million | -$22.41 Million | 0.61x | N/A |
| 2023 | $18.90 Million | $86.06 Million | -$17.36 Million | 0.22x | N/A |
| 2024 | $8.28 Million | $89.83 Million | -$19.18 Million | 0.09x | N/A |
Competitor Companies of DIGN by Market Capitalization
Companies near Dignitana AB in the global market cap rankings as of September 17, 2026. Review Dignitana AB tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Dignitana AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.42 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #232 globally with a market cap of $107.98 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.42 Billion | $102.03 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.75 |
| #232 | Stryker Corporation | NYSE:SYK | $107.98 Billion | $281.50 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Dignitana AB Historical Marketcap From 2015 to 2025
Between 2015 and today, Dignitana AB's market cap moved from $184.62 Million to $ 18.55 Million, with a yearly change of -17.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | Skr18.55 Million | +124.08% |
| 2024 | Skr8.28 Million | -56.19% |
| 2023 | Skr18.90 Million | -57.50% |
| 2022 | Skr44.46 Million | -41.44% |
| 2021 | Skr75.93 Million | +6.31% |
| 2020 | Skr71.42 Million | -3.96% |
| 2019 | Skr74.37 Million | +56.00% |
| 2018 | Skr47.67 Million | +78.57% |
| 2017 | Skr26.70 Million | -84.04% |
| 2016 | Skr167.28 Million | -9.39% |
| 2015 | Skr184.62 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 24th, 2026 the market cap of Dignitana AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.55 Million USD |
| MoneyControl | $18.55 Million USD |
| MarketWatch | $18.55 Million USD |
| marketcap.company | $18.55 Million USD |
| Reuters | $18.55 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Dignitana AB
Dignitana AB (publ), a medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from chemotherapy treatments, as well as for patients receiving chemotherapy to treat other solid tumors. The company was incorporated in 2007 is headquarter… Read more